adultmeltus - परिणामों की खोज

yondelis 1 mg

megapharm ltd - trabectedin - powder for concentrate for solution for injection - trabectedin 1 mg/vial - trabectedin - trabectedin - yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

exubera

pfizer limited - insulin human - diabetes mellitus - drugs used in diabetes - exubera is indicated for the treatment of adult patients with type 2 diabetes mellitus notadequately controlled with oral antidiabetic agents and requiring insulin therapy.exubera is also indicated for the treatment of adult patients with type 1 diabetes mellitus, inaddition to long or intermediate acting subcutaneous insulin, for whom the potential benefits ofadding inhaled insulin outweigh the potential safety concerns (see section 4.4).

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

slentrol

zoetis belgium sa - dirlotapide - antiobesity preparations, excl. diet products - dogs - as an aid in the management of overweight and obesity in adult dogs. to be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

intuniv

takeda pharmaceuticals international ag ireland branch - guanfacine hydrochloride - attention deficit disorder with hyperactivity - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv must be used as a part of a comprehensive adhd treatment programme, typically including psychological, educational and social measures.,

यूरोपीय संघ - अंग्रेज़ी - EMA (European Medicines Agency)

modigraf

astellas pharma europe b.v. - tacrolimus - graft rejection - immunosuppressants - prophylaxis of transplant rejection in adult and paediatric, kidney, liver or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult and paediatric patients.